Histopathology of post-embolized meningiomas

American Journal of Surgical Pathology

Volumn 20, Issue 10, 1996, Pages 1224-1230

  Ng, Ho Keung ^a   Poon, Wai Sang ^a   Goh, Keith ^a   Chan, Michael S Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Embolization; Meningiomas; MIB1 antigen; Proliferating cell nuclear antigen; Tumor necrosis

Indexed keywords

CYCLINE; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; TUMOR NECROSIS;

EID: 0029815224     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199610000-00008     Document Type: Article

References (27)

1. Burger PC, Scheithauer BW. Tumors of the central nervous system. Washington, D.C.: Armed Forces Institute of Pathology. 1994. (Atlas of tumor pathology, 3rd series).
2. Burger PC, Scheithauer BW, Vogel FS. Surgical pathology of the nervous system and its coverings, 3rd ed. New York: Churchill Livingstone, 1991.
3. Halbach VV, Hieshima GB, Higashida RT, David CF. Endovascular therapy of head and neck tumors. In: Vinuela F, ed. International neuroradiology: endovascular therapy of the central nervous system. New York: Raven Press, 1992:17-28.
4. Hayashi T, Shojima K, Utsunomiya H, Moritaka K, Honda E. Subarachnoid hemorrhage after preoperative embolization of a cystic meningioma. Surg Neurol 1987;27:295-300.
5. Hsu DW, Pardo FS, Efird JT, Lingood RM, Hedley-Whyte ET. Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 1994;53:247-55.
6. Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy and outcome. Surg Neurol 1986;25:233-42.
7. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB1 monoclonal antibody on archival material. Acta Neuropathol 1994;87:47-54.
8. Kepes JJ, Yarde WL. Visualization of injected embolic material (polyvinyl. alcohol) in paraffin sections with Verhoeff-Van Gieson elastica stain. Am J Surg Pathol 1995;19:709-11.
9. Khoshyomn S, Maier H, Morimura T, Kitz K, Budka H. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens. Acta Neuropathol 1993;86:582-9.
10. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. In: World Health Organization, International Classification of Tumours. Berlin: Springer-Verlag, 1993.
11. Lasjaunias P, Berenstein A. Surgical neuroangiography II: endovascular treatment of craniofacial lesions. New York: Springer Verlag, 1987:97.
12. Louis DN, Edgerton S, Thor AD, Hedley-Whyte ET. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol 1991;81:675-9.
13. Macpherson P. The value of pre-operative embolisation of meningioma estimated subjectively and objectively. Neuroadiology 1991;33:334-7.
14. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 1993;33:955-63.
15. Manelfe C, Lasjaunias P, Ruscalleda J. Preoperative embolization of intracranial meningiomas. Am J Neuroradiol 1986;7:963-72.
16. McKeever PE, Blaivas M. The brain, spinal cord and meninges. In: Sternberg SS, ed. Diagnostic surgical pathology, 2nd ed. New York: Raven Press, 1994:454-60.
17. McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF. Atypical and malignant meningiomas: Importance of micronecrosis as a prognostic indicator. Histopathology 1993; 23:349-53.
18. Nagashima G, Aoyagi M, Wakimoto H, Tamaki M, Ohno K, Hirakawa K. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Neurosurgery 1995;37:478-83.
19. Ng HK. Atypical and malignant meningioma: any easy diagnostic criteria? Adv Anat Pathol 1994;1:44-8.
20. Ohta M, Iwaki T, KitamotoT, Takeshita I, Tateishi J, Fukui M. MIB1 staining index and scoring of histologic features in meningiomas. Indicators for the prediction of biologic potential and postoperative management. Cancer 1994;74:3176-89.
21. Onda K, Davies RL, Shibuya M, Wilson CB, Hoshino T. Correlation between the bromodeoxyuridine labeling index and MIB-1 and Ki67 proliferating cell indices in cerebral gliomas. Cancer 1994;74:1921-6.
22. Paulus W, Meixensberger J, Hofmann E, Roggendorf W. Effect of embolisation of meningioma on Ki-67 proliferation index. J Clin Pathol 1993;46:876-7.
23. Richter H-P, Schachenmayr W. Preoperative embolization of intracranial meningiomas. Neurosurgery 1983;13:261-8.
24. Russell DS, Rubinstein LJ. Pathology of tumours of the Nervous System, 5th ed. London: Edward Arnold, 1989.
25. Shibuya M, Satoyuki I, Miwa T, Davies RL, Wilson CB, Hoshino T. Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Cancer 1993;71:199-206.
26. Suyama T, Tamaki N, Fujiwara K, Hamano S, Kimura M, Matsumoto S. Peritumoral and intratumoral hemorrhage after gelatin sponge embolization of malignant meningioma: case report. Neurosurgery 1987;21:944-6.
27. Younis GA, Sawaya R, DeMonte F, Hess KR, Albrecht S, Bruner JA. Aggressive meningeal tumors: review of a series. J Neurosurg 1995;82:17-27.